AFYREN Advances Industrial Strategy with Continuous Production at AFYREN NEOXY

AFYREN has announced a new phase in its industrial strategy as its first plant, AFYREN NEOXY, achieves continuous production, marking a major milestone. This development advances its commercialization efforts, with hundreds of tons of bio-based acids produced and secured revenue of €165 million from contracts, set to be executed over the coming years.

The plant aims for significant production revenue in 2025, projected in the low single-digit million euros range, with a break-even target within a few quarters. AFYREN plans to use this success as a springboard for further expansion, including building and operating three plants.

AFYREN NEOXY's continuous production is significant, proving the reliability of its industrial-scale operations. This positions AFYREN as a leader in sustainable green technology, with ambitious goals for future growth centered around three production sites and a revenue target of €150 million at full capacity.